Phase 4 N=50 Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty
Intracapsular Fracture of Femur · Femoral Neck Fractures · Hip Hemiarthroplasty
Primary: Post-operative Pain — 3.29; 2.64 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=28 A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.
Submental Fat
Primary: Safety: Adverse Events Follow up — 8; 4; 10; 6 Participants
N/A N=20 Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
High Grade Anal Canal Squamous Intraepithelial Neoplasia · Human Immunodeficiency Virus
Primary: Development of Spanish-language Version of the Anal Cancer/High-grade Squamous Intraepithelial Lesions (HSIL) Outcomes Research (ANCHOR) Health-related Quality of Life…
Phase 3 N=25 Phase III Copanlisib in Rituximab-refractory iNHL
Lymphoma, Non-Hodgkin
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAE)s — 17; 7; 7; 24 Participants
Phase 2 N=200 This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
Schizophrenia
Primary: Change From Baseline in Neurocognitive Function as Measured by the Neurocognitive Composite Score of the Measurement and Treatment Research to Improve Cognition in…
Phase 2 N=67 ACP-01 in Patients With Critical Limb Ischemia
Critical Limb Ischemia
Primary: Wound Size, Amputation or Survival — 12; 3 participants — p=0.258
N/A N=1,555 Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon
Gastroenteritis · Dehydration
Primary: Estimating the Incidence of Rotavirus Gastroenteritis Associated Hospitalization in Children < 5 Years of Age — 428 Participants
Phase 2 N=25 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease
Alzheimer's Disease
Primary: Part 1: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 5; 4; 1; 2 Participants
N/A N=60 Behavioral Economics to Improve Antihypertensive Therapy Adherence
Hypertension · Medication Adherence
Primary: Electronically Measured Mean Medication Adherence During Intervention — 87; 95; 92 Percentage of Timely Med Adherence
Phase 3 N=140 A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
Rheumatoid Arthritis
Primary: Number of Subjects With Positive Anti-Drug Antibodies (ADA) on Day 1 — 3; 1 Participants
Phase 2 N=12 Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks
Flank Mass
Primary: Number of Participants With Treatment-related Adverse Events [AEs] — 12; 12; 9; 12 participants
N/A N=1,507 Consumer Perceptions of Waterpipe Tobacco Packaging and Digital Marketing Claims
Waterpipe Tobacco Smoking
Primary: Willingness to Try Hookah Tobacco (Packaging Task ) — 1.9; 1.87; 1.9; 1.63 score on a scale
N/A N=65 Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder
Opioid-use Disorder
Primary: Smartphone Sensor Data — 94.2 mean percentage of days
N/A N=310 Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers
Distress · Caregiver
Primary: Change in Caregiver Health - Health Risks — 15.53; 14.65; 15.02; 14.80 score on a scale
N/A N=269 Effect of Medical Marijuana on Neurocognition and Escalation of Use
Pain · Insomnia · Depression
Primary: Mean Difference in Number of Cannabis Use Disorder Symptoms Averaged Over 2, 4, and 12 Weeks — 0.39; 0.12 score on a scale — p=<0.001